About: Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2001 (uk) im September 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2001 (ast) scientific article published on 01 September 2001 (en) գիտական հոդված հրատարակված 2001 թվականի սեպտեմբերի 1-ին (hy)
publication date	wds:Q63729313-5C900FAF-C312-4AC0-8C57-BA13B2784D80
publication date	2001-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q63729313-DFC7E872-BE5B-4E95-933F-A48C4E3CAC41
language of work or name	English
author name string	wds:Q63729313-3CB79C12-7856-4A3B-B9A7-5CC56705CADB wds:Q63729313-764DDA7B-FE3F-4BFE-A8E7-D0F93D2C8294 wds:Q63729313-FD808C40-F412-4472-B954-779C7703A72A
author name string	Vestbo J Tybjaerg-Hansen A Lange P
rdfs:label	Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease (en) Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease (nl)
skos:prefLabel	Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease (en) Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease (nl)
name	Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease (en) Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease (nl)
author	wds:Q63729313-39BB0167-A9DF-4B7C-90B9-2A06C79C50BC wds:Q63729313-D20713FA-5DC8-411E-93B6-3720B4521C2F
author	Børge G. Nordestgaard Morten Dahl
title	wds:Q63729313-C146BA2F-84BE-422E-94A8-92DCC14C401B
title	Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease (en)
page(s)	wds:Q63729313-4E034012-7057-4A0F-B3B9-44279D9AFCE1
page(s)	1008-1011
instance of	wds:Q63729313-915FD563-804F-470E-B276-A1AC43A16CE7
instance of	scholarly article
main subject	wds:Q63729313-894CC154-1DD7-42F6-9C34-6B985A7C23F0
main subject	chronic obstructive pulmonary disease
PubMed ID	wds:Q63729313-F72A17F0-1E59-4C2C-8C91-3766B24A4317
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11587987
PubMed ID	11587987
published in	wds:Q63729313-4BDE4288-E4D6-422B-BF49-0B8FEE26228D
published in	American Journal of Respiratory and Critical Care Medicine
issue	wds:Q63729313-C3983873-00F9-4B1D-81D1-0E7B826AC1E2
volume	wds:Q63729313-64A8CBE8-8B53-4B27-ABE6-D8EEE22C5926
issue	6
volume	164
DOI	wds:Q63729313-A2A9EE77-19AE-42BE-BC9A-49CDEEC69CBB
DOI	http://dx.doi.org/10.1164/AJRCCM.164.6.2010067
DOI	10.1164/AJRCCM.164.6.2010067
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q63729313
is cites work of	Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Association between exhaled nitric oxide and systemic inflammatory markers Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey Frailty and respiratory impairment in older persons. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema Systemic inflammation in chronic obstructive pulmonary disease: a population-based study Determinants of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease: a prospective cohort study Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study Perinatal stress and early life programming of lung structure and function Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease Inflammatory markers and longitudinal lung function decline in the elderly Airway and systemic inflammation and decline in lung function in patients with COPD. A unique protein profile of peripheral neutrophils from COPD patients does not reflect cytokine-induced protein profiles of neutrophils in vitro Gender differences in the association between C-reactive protein, lung function impairment, and COPD. Extreme values of hemoglobin a1c are associated with increased risks of chronic obstructive pulmonary disease in patients with type 2 diabetes: a competing risk analysis in national cohort of Taiwan diabetes study COPD association and repeatability of blood biomarkers in the ECLIPSE cohort Accuracy of D-dimer/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study. Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Biomarkers in chronic obstructive pulmonary disease Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD. Multiple biomarkers predict disease severity, progression and mortality in COPD. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD. The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial. The value of blood cytokines and chemokines in assessing COPD. Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones Endothelial Glycocalyx Layer: A Possible Therapeutic Target for Acute Lung Injury during Lung Resection. Anticoagulation therapy in patients with chronic obstructive pulmonary disease in the acute exacerbation stage Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature Association between exhaled nitric oxide and systemic inflammatory markers Association of circulating adhesion molecules with lung function. The CARDIA study Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker. [Treatment failure of acute exacerbations of chronic obstructive airways disease risk factors and clinical relevance] Ischaemic heart disease among livestock and agricultural workers The Importance of Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article Fibrinogen as a potential biomarker for clinical phenotype in patients with chronic obstructive pulmonary disease Asthma and asthma severity among African American adults in the Jackson Heart Study Pathogenesis of COPD.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software